RIVAROXABAN NOBEL vascular cpr pellic 2.5 mg 2x98

7680680210024 CH-68021 B01AF01 06.03.0.

Active substances:

No images available

Details

Product number
6802101
CPT
-
Packaging group
2 x 98
Unit
Tablette(n)
Composition
rivaroxabanum 2.5 mg, mannitolum, carmellosum natricum conexum, hypromellosum, natrii laurilsulfas, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, macrogola, E 171, E 172 (flavum) pro compresso obducto corresp. natrium 0.33 mg.

Articles (1)

Rivaroxaban NOBEL vascular 2.5 mg, Filmtabletten
Filmtabletten
2 x 98
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/03/2026
Patient information leaflet
Français
01/03/2026
Patient information leaflet
Italien
01/03/2026
Professional SmPC
Allemand
01/03/2026
Professional SmPC
Français
01/03/2026
Professional SmPC
Italien
01/03/2026

Detailed composition

Substance Quantity Type Category
rivaroxabanum
2.5 MG Substance Wirkstoff (Principe actif)
mannitolum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
hypromellosum
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
cellulosum microcristallinum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogola
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
natrium
0.33 MG Substance HBESI

Reimbursement information

Public price
CHF 118.55
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/03/2026

Authorization holder

NOBEL Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
68021
Drug name
Rivaroxaban NOBEL vascular, Filmtabletten
Galenic form
FILM
ATC Code
B01AF01
Authorization status
Z
Dispensation category
B
First authorization
05/05/2022
Authorization expiration date
04/05/2027
IT number
06.03.0.
Domain
Human medicine
Field of application
In Kombination mit Acetylsalicylsäure zur Prävention schwerwiegender atherothrombotischer Ereignisse bei Patienten mit koronarer Herzkrankheit oder manifester peripherer arterieller Gefässerkrankung und einem hohen Risiko für ischämische Ereignisse

Packaging details

Description (FR)
RIVAROXABAN NOBEL vascular cpr pellic 2.5 mg 2x98
Description (DE)
RIVAROXABAN NOBEL vascular Filmtabl 2.5 mg 2x98 St
Market launch
01/03/2026
Narcotic (BTM)
No

Original drug

Xarelto, Filmtabletten
CHF 15.30
View original

Other packaging sizes

RIVAROXABAN NOBEL vascular cpr pellic 2.5 mg 56 pc
56 TABL
View
Buy us a coffee Explore the data